|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.380 USD | +3.03% |
|
-2.46% | +32.22% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Other Pharmaceuticals | +3.03% | -2.46% | +32.22% | +64.14% | +50.63% | 192M |  |  | |
- Stock Market
- Stocks
- PLX Stock
- Charts Protalix BioTherapeutics, Inc.
- Relative Strength Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
